Literature DB >> 11417752

Zoster in patients infected with HIV: a review.

A Vafai1, M Berger.   

Abstract

Varicella-zoster virus (VZV), a member of the human herpesvirus family, causes childhood chickenpox (varicella), becomes latent in sensory ganglia, and reactivates years later in immunocompromised and elderly persons to produce shingles (herpes zoster). Early in the AIDS epidemic, zoster was noted in adults and children infected with HIV. Severe and debilitating zoster-associated dermatological, ophthalmic, and neurological complications may occur in patients infected with HIV. Antiviral therapy can modify the duration of zoster and alleviate its attendant complications. Varicella vaccine may boost the immunity and prevent virus reactivation. VZV immune globulin (VZIG) prevents or modifies clinical illness in persons who have been exposed to varicella or zoster.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11417752     DOI: 10.1097/00000441-200106000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  19 in total

Review 1.  Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective.

Authors:  Robert W Johnson; Marie-José Alvarez-Pasquin; Marc Bijl; Elisabetta Franco; Jacques Gaillat; João G Clara; Marc Labetoulle; Jean-Pierre Michel; Luigi Naldi; Luis S Sanmarti; Thomas Weinke
Journal:  Ther Adv Vaccines       Date:  2015-07

2.  Presentation and management of herpes zoster (shingles) in the geriatric population.

Authors:  Kenneth R Cohen; Rebecca L Salbu; Jerry Frank; Igor Israel
Journal:  P T       Date:  2013-04

3.  A young man with loin pain.

Authors:  Sf Tong
Journal:  Malays Fam Physician       Date:  2007-12-31

4.  Subclinical reactivation of varicella zoster virus in all stages of HIV infection.

Authors:  Marius Birlea; Gabriele Arendt; Eser Orhan; D Scott Schmid; William J Bellini; Christian Schmidt; Don Gilden; Randall J Cohrs
Journal:  J Neurol Sci       Date:  2011-03-17       Impact factor: 3.181

5.  Impact of CCR5 Delta32/+ deletion on herpes zoster among HIV-1-infected homosexual men.

Authors:  Anneke Krol; Ruud Lensen; Jan Veenstra; Maria Prins; Hanneke Schuitemaker; Roel A Coutinho
Journal:  Eur J Epidemiol       Date:  2006-05-16       Impact factor: 8.082

6.  Compounds that target host cell proteins prevent varicella-zoster virus replication in culture, ex vivo, and in SCID-Hu mice.

Authors:  Jenny Rowe; Rebecca J Greenblatt; Dongmei Liu; Jennifer F Moffat
Journal:  Antiviral Res       Date:  2010-03-20       Impact factor: 5.970

Review 7.  Neuromuscular diseases associated with HIV-1 infection.

Authors:  Jessica Robinson-Papp; David M Simpson
Journal:  Muscle Nerve       Date:  2009-12       Impact factor: 3.217

8.  Detection and genotyping of varicella-zoster virus by TaqMan allelic discrimination real-time PCR.

Authors:  Paul A Campsall; Nicholas H C Au; Julie S Prendiville; David P Speert; Rusung Tan; Eva E Thomas
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

Review 9.  Optimal timing of routine vaccination in HIV-infected persons.

Authors:  Heidi M Crane; Shireesha Dhanireddy; H Nina Kim; Christian Ramers; Timothy H Dellit; Mari M Kitahata; Robert D Harrington
Journal:  Curr HIV/AIDS Rep       Date:  2009-05       Impact factor: 5.071

10.  Cerebrospinal fluid HIV-1 compartmentalization in a patient with AIDS and acute varicella-zoster virus meningomyeloradiculitis.

Authors:  E Liana Falcone; Ademiposi A Adegbulugbe; Virginia Sheikh; Hiromi Imamichi; Robin L Dewar; Dima A Hammoud; Irini Sereti; H Clifford Lane
Journal:  Clin Infect Dis       Date:  2013-05-31       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.